Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

01/02/2019 04:30

Feb 1 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             72.58               76.89            94.80    
                 (-5.6 pct)          (-2.6 pct)       (-3.7 pct)  
  Operating         19.90               23.71            22.50    
                 (-16.0 pct)         (-5.0 pct)       (-18.2 pct) 
  Recurring         20.25               24.06            22.80    
                 (-15.8 pct)         (-4.6 pct)       (-18.1 pct) 
  Net               14.25               16.86            16.40    
                 (-15.5 pct)         (-6.3 pct)       (-13.9 pct) 
  EPS            356.84 yen          416.06 yen       412.91 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T